EC Number |
Inhibitors |
Structure |
---|
2.4.1.255 | (2Z)-2-[(4-chlorophenyl)imino]-4-oxo-3-(2-tricyclo[3.3.1.1(3,7)]dec-1-ylethyl)-1,3-thiazinane-6-carboxylic acid |
donor analogue displacement probes |
|
2.4.1.255 | 1-(4-acetamidophenyl)-4-(diphenylhydroxymethyl)-1H-1,2,3-triazole |
- |
|
2.4.1.255 | 1-(4-acetamidophenyl)-4-(naphthalen-2-yl)-1H-1,2,3-triazole |
i.e. APNT, cell-permeable inhibitor, able to inhibit OGlcNAcylation in cells without significant effects on cell viability |
|
2.4.1.255 | 1-(4-acetamidophenyl)-4-([1,1'-biphenyl]-4-yl)-1H-1,2,3-triazole |
i.e. APBT, cell-permeable inhibitor, able to inhibit OGlcNAcylation in cells without significant effects on cell viability |
|
2.4.1.255 | 1-(4-chloroacetamidophenyl)-4-(diphenylhydroxymethyl)-1H-1,2,3-triazole |
- |
|
2.4.1.255 | 1-(4-chloroacetamidophenyl)-4-(naphthalen-2-yl)-1H-1,2,3-triazole |
- |
|
2.4.1.255 | 1-(4-chloroacetamidophenyl)-4-([1,1'-biphenyl]-4-yl)-1H-1,2,3-triazole |
- |
|
2.4.1.255 | 2,4,5,6-tetraoxypyrimidine |
- |
|
2.4.1.255 | 3-(2-adamantanylethyl)-2-[(4-chlorophenyl)azamethylene]-4-oxo-1,3-thiazaperhydroine-6-carboxylic acid |
- |
|
2.4.1.255 | 3-(4-cyanobenzylthio)-1-(thiophen-2-yl)-5,6,7,8-tetrahydroisoquinoline-4-carboxylic acid |
donor analogue displacement probes |
|